HCA Healthcare is an American for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owns and operates 186 hospitals and approximately 2,000 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom.
| Revenue (TTM) | $78.01B |
| Gross Profit (TTM) | $33.22B |
| EBITDA | $15.75B |
| Operating Margin | 15.20% |
| Return on Equity | 136.30% |
| Return on Assets | 12.30% |
| Revenue/Share (TTM) | $345.31 |
| Book Value | $-30.47 |
| Price-to-Book | 291.34 |
| Price-to-Sales (TTM) | 1.12 |
| EV/Revenue | 1.783 |
| EV/EBITDA | 8.77 |
| Quarterly Earnings Growth (YoY) | 11.60% |
| Quarterly Revenue Growth (YoY) | 8.70% |
| Shares Outstanding | $221.84M |
| Float | $144.32M |
| % Insiders | 16.61% |
| % Institutions | 78.99% |
Volatility is currently contracting
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA).
HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer, effective Sept. 1, 2026. Also, effective Sept. 1, Charles Gressle, president of HCA Healthcare's East Florida Division, has been appointed president of HCA Healthcare's new Ambulatory Operations Group. Dr. Schlosser will succeed Dr. Michael Cuffe, who a.
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK--(BUSINESS WIRE)---- $HCA #classaction--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE INVESTIGATION]What Happened?On July 14, 2026, HCA Healthcare issued a press release reporting its preliminary financial and operat.
NEW YORK, July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc.("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. (“HCA” or the “Company”) (NYSE: HCA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
U.S. Fund A Shares (without sales charge) posted a return of -0.04% in second quarter of 2026. Leading contributors in the First Eagle U.S. Fund this quarter included Alphabet Inc. Class C, Texas Instruments, Elevance Health, Bank of New York Mellon Corporation and Cummins. The leading detractors in the quarter were First Eagle Global Real Assets Cayman Fund Ltd. USD, HCA Healthcare, Charter Communications, Inc. Class A, Exxon Mobil and Salesforce.
HCA Healthcare Inc. (NYSE:HCA) on Friday posted upbeat second-quarter earnings.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HCA and any ticker you trade — then tracks every position and per-strategy win rate.
